These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8907933)

  • 1. Immunosuppressive power and limitations of FK 506 for prevention and treatment of graft-vs-host disease after small bowel transplantation.
    Platz KP; Mueller AR; Langrehr JM; Neuhaus P; Schraut WH
    Transplant Proc; 1996 Oct; 28(5):2523-4. PubMed ID: 8907933
    [No Abstract]   [Full Text] [Related]  

  • 2. Fulminant graft-versus-host disease after FK 506 treatment in fully allogeneic small bowel transplantation.
    de Bruin RW; HogenEsch H; Heineman E; Jeekel J; Marquet RL
    Transplant Proc; 1991 Dec; 23(6):3257-9. PubMed ID: 1721429
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of rapamycin on orthotopic small bowel transplantation in the rat.
    Chen H; Wu J; Xu D; Aboujaoude M; Stepkowski S; Kahan B; Daloze P
    Transplant Proc; 1992 Jun; 24(3):1157-8. PubMed ID: 1604567
    [No Abstract]   [Full Text] [Related]  

  • 4. Leflunomide immunosuppression in rat small intestinal transplantation.
    Foster PF; Xiao F; Kociss K; Chong AS; Sankary HN; McChesney L; Cohn S; Williams JW
    Transplant Proc; 1994 Jun; 26(3):1599-600. PubMed ID: 8030053
    [No Abstract]   [Full Text] [Related]  

  • 5. Maintenance of unresponsiveness by short-term pulse therapy with FK 506 in rat transplantation.
    Hayakawa K; Hata M; Nishiyama T; Ohashi M; Ishikawa M
    Transplant Proc; 1996 Jun; 28(3):1830-1. PubMed ID: 8658904
    [No Abstract]   [Full Text] [Related]  

  • 6. Donor pretreatment with anti-T-cell receptor monoclonal antibodies prevents graft-vs-host disease in brequinar-treated small bowel allograft recipients.
    Wang M; Stepkowski SM; Kahan BD
    Transplant Proc; 1995 Feb; 27(1):383. PubMed ID: 7879029
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapamycin suppression of host-versus-graft and graft-versus-host disease in MHC-mismatched rats.
    Fabian MA; Denning SM; Bollinger RR
    Transplant Proc; 1992 Jun; 24(3):1174. PubMed ID: 1604575
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolonged small bowel graft survival using photochemotherapy and low-dose FK 506.
    Toyama Y; Murase N; Galvao FH; Sakamoto T; Nomoto M; Starzl TE; Todo S
    Transplant Proc; 1996 Oct; 28(5):2506-7. PubMed ID: 8907924
    [No Abstract]   [Full Text] [Related]  

  • 9. Rejection and survival after total orthotopic liver-small bowel allotransplantation in pigs immunosuppressed with FK 506.
    Velio P; Tarantino C; Bertoglio C; Guffanti E; Bardella MT; Biffi R; Andreoni B; Rossi G; Gatti S; Piazzini A; Fassati LR; Galmarini D
    Transplant Proc; 1996 Oct; 28(5):2529-30. PubMed ID: 8907936
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of FK 506 in combination with prednisolone on the graft-vs-host reaction after small bowel transplantation in rats.
    Orita T; Tanaka S; Orita K
    Transplant Proc; 1994 Jun; 26(3):1594-6. PubMed ID: 7518147
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of cyclosporine, rapamycin and FK 506 the survival following allogeneic bone marrow transplantation.
    Markus PM; Cai X; Selvaggi G; Cooper M; Harnaha J; Fung JJ; Starzl TE
    Transplant Proc; 1991 Dec; 23(6):3232-3. PubMed ID: 1721418
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination therapy with FK 506 and RS61443 for rejection following allogeneic small bowel transplantation in rats.
    Yoshida S; Toyama Y; Aoki T; Nakamura J; Odaira H; Inagaki Y
    Transplant Proc; 2000 Nov; 32(7):2492-3. PubMed ID: 11120262
    [No Abstract]   [Full Text] [Related]  

  • 13. Synergistic effect of FK 506 and trifluoperazine on the immunosuppression in rat small bowel transplantation.
    Yamada T; Taguchi T; Nakao M; Rahman MS; Suita S
    Transplant Proc; 1996 Oct; 28(5):2511. PubMed ID: 8907927
    [No Abstract]   [Full Text] [Related]  

  • 14. Donor pretreatment with rapamycin delays rejection following intestinal allotransplantation.
    He G; Zhong R; Zhang Z; Garcia B; Black R; Duff J; Grant D
    Transplant Proc; 1992 Jun; 24(3):1178. PubMed ID: 1604577
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of FK 506 on the survival of rat small bowel allografts.
    Takeda Y; Okajima K; Iga C; Date K; Ryo T; Niki M; Asaka K; Tezuka K; Isozaki H
    Transplant Proc; 1991 Dec; 23(6):3251. PubMed ID: 1721426
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of FK 506 on bowel transplantation in rats.
    Hatazawa C; Yamaguchi M; Kato T; Koyama K
    Transplant Proc; 1992 Jun; 24(3):1177. PubMed ID: 1376517
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of FK 506 on orthotopic small bowel transplantation in rats.
    Utsunomiya H; Tanaka K; Uemoto S; Kato H; Nishizawa T; Yamamoto E; Ozawa K
    Transplant Proc; 1992 Jun; 24(3):1191. PubMed ID: 1376521
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunopharmacology of FK-506.
    Morris RE; Hoyt EG; Murphy MP; Shorthouse R
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1042-4. PubMed ID: 2468201
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of donor natural killer cells on lethal graft-versus-host disease following small bowel transplantation in the rat.
    Okamoto M; Arakawa K; Akioka K; Fujiwara I; Takeshita K; Oka T
    Transplant Proc; 1996 Oct; 28(5):2467-8. PubMed ID: 8907905
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunosuppressive effect of FK506 on orthotopic liver and small bowel xenotransplantation (xenoOLTx and SBTx).
    Zou XM; Yagihashi A; Tsuruma T; Matsuno T; Yamaguchi H; Asanuma K; Sasaki K; Hirata K
    Transplant Proc; 1996 Jun; 28(3):1437-9. PubMed ID: 8658729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.